| 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study | Lancet, The | 2021 | 1.3K |
| 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study | Lancet, The | 2021 | 149 |
| Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline | European Respiratory Journal | 2021 | 76 |
| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data | The Lancet Digital Health | 2021 | 58 |
| Improving lung health in low-income and middle-income countries: from challenges to solutions | Lancet, The | 2021 | 57 |
| Pharmacists' readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles | Research in Social and Administrative Pharmacy | 2021 | 46 |
| COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper | Allergy: European Journal of Allergy and Clinical Immunology | 2021 | 46 |
| Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial | Respiration | 2021 | 44 |
| The effect of respiratory activity, non-invasive respiratory support and facemasks on aerosol generation and its relevance to COVID-19 | Anaesthesia | 2021 | 35 |
| The immunodominant and neutralization linear epitopes for SARS-CoV-2 | Cell Reports | 2021 | 34 |
| Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study | Emerging Microbes and Infections | 2021 | 32 |
| ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020) | Allergy: European Journal of Allergy and Clinical Immunology | 2021 | 31 |
| Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes | European Respiratory Journal | 2021 | 28 |
| Integrative microbiomics in bronchiectasis exacerbations | Nature Medicine | 2021 | 26 |
| Therapeutic targets in lung tissue remodelling and fibrosis | Pharmacology & Therapeutics | 2021 | 25 |
| Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial | Clinical Infectious Diseases | 2021 | 24 |
| The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines | Vaccines | 2021 | 22 |
| ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice | Allergy: European Journal of Allergy and Clinical Immunology | 2021 | 21 |
| Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study | Lancet Respiratory Medicine,the | 2021 | 21 |
| Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis | Journal of Allergy and Clinical Immunology: in Practice | 2021 | 20 |
| Do Sex Differences in Physiology Confer a Female Advantage in Ultra-Endurance Sport? | Sports Medicine | 2021 | 20 |
| Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19 | Clinical Microbiology and Infection | 2021 | 19 |
| Global Initiative for Asthma (GINA) Strategy 2021 - Executive Summary and Rationale for Key Changes | American Journal of Respiratory and Critical Care Medicine | 2021 | 18 |
| Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review | Chest | 2021 | 15 |
| Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study | BMC Infectious Diseases | 2021 | 14 |
